Insulet Corporation

PODDleader

Insulet makes the Omnipod — the world's only tubeless insulin delivery system. Omnipod 5 is the first tubeless automated insulin delivery (AID) system, integrating with Dexcom's CGM for closed-loop glucose management.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($2.3B)

Datos estáticos (cargando finanzas en tiempo real…)

US Omnipod (40%)

International Omnipod (55%)

Drug Delivery (5%)

Composición de segmentos y clientes principales

Detalles del producto

Omnipod 5 (Automated Insulin Delivery)75%

Tubeless insulin pump with Omnipod 5 closed-loop system — world's first tubeless AID system.

Omnipod DASH (Traditional Pump)20%

Bluetooth-enabled tubeless pump without automated delivery.

Drug Delivery (Non-Diabetes)5%

Pod technology licensing for drug delivery beyond insulin.

Relaciones en la Cadena de Suministro

Socios

DexCom

Dexcom CGM integration with Omnipod 5

Impacto: critical feature

Contexto macro y de mercado

헬스케어Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de Insulet Corporation impulsado por IA.

Información de la Empresa

Sede Central

Acton, MA

Fundación

2000

Empleados

6,200

Sitio Web

insulet.com

Estado del sector — 헬스케어

Noticias del sector